Non-Animal Approaches for Toxicokinetics in Risk Evaluations of Food Chemicals

被引:32
|
作者
Punt, Ans [1 ]
Peijnenburg, Ad A. C. M. [1 ]
Hoogenboom, Ron L. A. P. [1 ]
Bouwmeester, Hans [1 ,2 ]
机构
[1] Wageningen Univ & Res, RIKILT, Akkermaalsbos 2, NL-6708 PD Wageningen, Netherlands
[2] Wageningen UR, Div Toxicol, Wageningen, Netherlands
关键词
in vitro kinetics; alternatives to animal testing; PBPK; regulatory acceptance; IN-VIVO EXTRAPOLATION; VITRO DIGESTION MODEL; DNA ADDUCT FORMATION; HEPATIC-CLEARANCE; SCALING FACTORS; DRUG DISCOVERY; POLYSTYRENE NANOPARTICLES; PHARMACOKINETIC MODELS; GASTROINTESTINAL-TRACT; SCIENTIFIC OPINION;
D O I
10.14573/altex.1702211
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The objective of the present work was to review the availability and predictive value of non-animal toxicokinetic approaches and to evaluate their current use in European risk evaluations of food contaminants, additives and food contact materials, as well as pesticides and medicines. Results revealed little use of quantitative animal or human kinetic data in risk evaluations of food chemicals, compared with pesticides and medicines. Risk evaluations of medicines provided sufficient in vivo kinetic data from different species to evaluate the predictive value of animal kinetic data for humans. These data showed a relatively poor correlation between the in vivo bioavailability in rats and dogs versus that in humans. In contrast, in vitro (human) kinetic data have been demonstrated to provide adequate predictions of the fate of compounds in humans, using appropriate in vitro-in vivo scalers and by integration of in vitro kinetic data with in silico kinetic modelling. Even though in vitro kinetic data were found to be occasionally included within risk evaluations of food chemicals, particularly results from Caco-2 absorption experiments and in vitro data on gut-microbial conversions, only minor use of in vitro methods for metabolism and quantitative in vitro-in vivo extrapolation methods was identified. Yet, such quantitative predictions are essential in the development of alternatives to animal testing as well as to increase human relevance of toxicological risk evaluations. Future research should aim at further improving and validating quantitative alternative methods for kinetics, thereby increasing regulatory acceptance of non-animal kinetic data.
引用
收藏
页码:501 / 514
页数:14
相关论文
共 50 条
  • [31] Scientific Opinion on the risk posed by pathogens in food of non-animal origin. Part 2 (Salmonella in melons)
    Andreoletti, Olivier
    Baggesen, Dorte Lau
    Bolton, Declan
    Butaye, Patrick
    Cook, Paul
    Davies, Robert
    Fernandez Escamez, Pablo S.
    Griffin, John
    Hald, Tine
    Havelaar, Arie
    Koutsoumanis, Kostas
    Lindqvist, Roland
    McLauchlin, James
    Nesbakken, Truls
    Prieto Maradona, Miguel
    Ricci, Antonia
    Ru, Giuseppe
    Sanaa, Moez
    Simmons, Marion
    Sofos, John
    Threlfall, John
    EFSA JOURNAL, 2014, 12 (10)
  • [32] Prioritizing Substances of Genotoxic Concern for In-Depth Safety Evaluation Using Non-Animal Approaches: The Example of Food Contact Materials
    Van Bossuyt, Melissa
    Van Hoeck, Els
    Vanhaecke, Tamara
    Rogiers, Vera
    Mertens, Birgit
    ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2019, 36 (02) : 215 - 230
  • [33] Setting the stage for next-generation risk assessment with non-animal approaches: the EU-ToxRisk project experience
    M. J. Moné
    G. Pallocca
    S. E. Escher
    T. Exner
    M. Herzler
    S. Hougaard Bennekou
    H. Kamp
    E. D. Kroese
    Marcel Leist
    T. Steger-Hartmann
    B. van de Water
    Archives of Toxicology, 2020, 94 : 3581 - 3592
  • [34] Setting the stage for next-generation risk assessment with non-animal approaches: the EU-ToxRisk project experience
    Mone, M. J.
    Pallocca, G.
    Escher, S. E.
    Exner, T.
    Herzler, M.
    Bennekou, S. Hougaard
    Kamp, H.
    Kroese, E. D.
    Leist, Marcel
    Steger-Hartmann, T.
    van de Water, B.
    ARCHIVES OF TOXICOLOGY, 2020, 94 (10) : 3581 - 3592
  • [35] New non-animal drug test
    不详
    CHEMISTRY IN BRITAIN, 2003, 39 (07) : 11 - 11
  • [36] Revisiting the Non-Animal Peroxidase Superfamily
    Lazzarotto, Fernanda
    Turchetto-Zolet, Andreia Carina
    Margis-Pinheiro, Marcia
    TRENDS IN PLANT SCIENCE, 2015, 20 (12) : 807 - 813
  • [37] Advanced non-animal microsurgical exercises
    Crosby, NL
    Clapson, JB
    Buncke, HJ
    Newlin, L
    MICROSURGERY, 1995, 16 (09) : 655 - 658
  • [38] Non-animal alternatives and reduction in laboratory animal use
    Balls, M
    Fentem, J
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 1997, 25 (03): : 215 - 218
  • [39] Non-Animal Models in Dermatological Research
    Dellambra, Elena
    Odorisio, Teresa
    D'Arcangelo, Daniela
    Failla, Cristina M.
    Facchiano, Antonio
    ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2019, 36 (02) : 177 - 202
  • [40] Guiding principles for the implementation of non-animal safety assessment approaches for cosmetics: Skin sensitisation
    Goebel, Carsten
    Aeby, Pierre
    Ade, Nadege
    Alepee, Nathalie
    Aptula, Aynur
    Araki, Daisuke
    Dufour, Eric
    Gilmour, Nicola
    Hibatallah, Jalila
    Keller, Detlef
    Kern, Petra
    Kirst, Annette
    Marrec-Fairley, Monique
    Maxwell, Gavin
    Rowland, Joanna
    Safford, Bob
    Schellauf, Florian
    Schepky, Andreas
    Seaman, Chris
    Teichert, Thomas
    Tessier, Nicolas
    Teissier, Silvia
    Weltzien, Hans Ulrich
    Winkler, Petra
    Scheel, Julia
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2012, 63 (01) : 40 - 52